Remove solutions commercial-delivery
article thumbnail

Baxter to sell BPS business to Advent and Warburg Pincus for $4.25bn

Pharmaceutical Technology

Baxter International has signed a definitive agreement to sell its BioPharma Solutions (BPS) business to private equity investor Advent International and growth investor Warburg Pincus, in a deal valued at $4.25bn in cash. The business will offer services from clinical research to commercial deployment for clients.

article thumbnail

Scilex buys rights to acute migraine treatment Elyxyb in Canada and the US

Pharmaceutical Technology

Sorrento Therapeutics’ majority-owned subsidiary Scilex has acquired rights to Elyxyb (celecoxib) oral solution in Canada and the US. It is formulated using a self-micro-emulsifying drug delivery system that improves the drug’s bioavailability and solubility.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How a specialized commercial program management team can improve your customer experience and accelerate commercialization 

Pharmaceutical Technology

With over 18 years of experience, Alexander Dragitsch is a commercial customer service contract manufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. Alex and his team have the significant responsibility of managing various commercial programs for more than 40 marketed products.

article thumbnail

XtalPi announces $250m AI drug discovery collaboration with Eli Lilly

Pharmaceutical Technology

The two companies will use XtalPi’s integrated AI capabilities and robotics platform for the de novo [without consideration of previous instances] design and delivery of drug candidates for an undisclosed target. XtalPi brings together AI “dry lab” algorithms and “wet lab” robotics to drive innovation.

Drugs 278
article thumbnail

Leading commercial packaging companies in contract marketing

Pharmaceutical Technology

The pharmaceutical industry requires specialised and cost-effective commercial packaging solutions to improve efficiency and preserve the integrity of products through the entire supply chain, from primary packaging and labelling to shipping, delivery, storage and distribution to end users.

Packaging 130
article thumbnail

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)

Pharma Mirror

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it had entered into a commercial supply agreement with Blueprint Medicines following FDA approval of GAVRETO™ (pralsetinib).

article thumbnail

RareMed Expands Concierge Patient Support Services to Complex Conditions

Drug Channels

Today’s guest post comes from Justin Smerker, VP of Business Development at RareMed Solutions. Justin introduces us to RareMed Solutions, a patient service provider that caters to patients with complex and rare diseases. This Feed is for personal non-commercial use only. d/b/a Drug Channels Institute.